|
1
|
Cheung NK and Dyer MA: Neuroblastoma:
Developmental biology, cancer genomics and immunotherapy. Nat Rev
Cancer. 13:397–411. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
2
|
Li Y, Li W, Zhang JG, Li HY and Li YM:
Downregulation of tumor suppressor menin by miR-421 promotes
proliferation and migration of neuroblastoma. Tumour Biol.
35:10011–10017. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Maris JM, Hogarty MD, Bagatell R and Cohn
SL: Neuroblastoma. Lancet. 369:2106–2120. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Li D, Mei H, Qi M, Yang D, Zhao X, Xiang
X, Pu J, Huang K, Zheng L and Tong Q: FOXD3 is a novel tumor
suppressor that affects growth, invasion, metastasis and
angiogenesis of neuroblastoma. Oncotarget. 4:2021–2044. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Qiao J, Lee S, Paul P, Qiao L, Taylor CJ,
Schlegel C, Colon NC and Chung DH: Akt2 regulates metastatic
potential in neuroblastoma. PLoS One. 8:e563822013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kim YS, Lee HA, Lim JY and Kim Y, Jung CH,
Yoo SH and Kim Y: β-Carotene inhibits neuroblastoma cell invasion
and metastasis in vitro and in vivo by decreasing level of
hypoxia-inducible factor-1α. J Nutr Biochem. 25:655–664. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Pan M, Han L, Lu H, Hao X and Dong
Q: MiR-338-3p suppresses neuroblastoma proliferation, invasion and
migration through targeting PREX2a. FEBS Lett. 587:3729–3737. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu WK, Lee CW, Cho CH, Fan D, Wu K, Yu J
and Sung JJ: MicroRNA dysregulation in gastric cancer: A new player
enters the game. Oncogene. 29:5761–5771. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sassen S, Miska EA and Caldas C: MicroRNA:
Implications for cancer. Virchows Arch. 452:1–10. 2008. View Article : Google Scholar
|
|
11
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu D, Liu C, Wang X, Ingvarsson S and
Chen H: MicroRNA-451 suppresses tumor cell growth by
down-regulating IL6R gene expression. Cancer Epidemiol. 38:85–92.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu N, Jiang N, Guo R, Jiang W, He QM, Xu
YF, Li YQ, Tang LL, Mao YP, Sun Y and Ma J: MiR-451 inhibits cell
growth and invasion by targeting MIF and is associated with
survival in naso-pharyngeal carcinoma. Mol Cancer. 12:1232013.
View Article : Google Scholar
|
|
15
|
Liu X, Zhang X, Xiang J, Lv Y and Shi J:
miR-451: Potential role as tumor suppressor of human hepatoma cell
growth and invasion. Int J Oncol. 45:739–745. 2014.PubMed/NCBI
|
|
16
|
Lv G, Hu Z, Tie Y, Du J, Fu H, Gao X and
Zheng X: microRNA-451 regulates activating transcription factor 2
expression and inhibits liver cancer cell migration. Oncol Rep.
32:1021–1028. 2014.PubMed/NCBI
|
|
17
|
Zeng T, Peng L, Chao C, Fu B, Wang G, Wang
Y and Zhu X: MiR-451 inhibits invasion and proliferation of bladder
cancer by regulating EMT. Int J Clin Exp Pathol. 7:7653–7662.
2014.
|
|
18
|
Wang Y, Liang Z, Gao Y, et al: Factors
influencing circulating MicroRNA level in the studies of
hepatocellular carcinoma biomarker. Neoplasma. 62:798–804. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bandres E, Bitarte N, Arias F, Agorreta J,
Fortes P, Agirre X, Zarate R, Diaz-Gonzalez JA, Ramirez N, Sola JJ,
et al: microRNA-451 regulates macrophage migration inhibitory
factor production and proliferation of gastrointestinal cancer
cells. Clin Cancer Res. 15:2281–2290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guo J, Dong Q, Fang Z, et al:
Identification of miRNAs that are associated with tumor metastasis
in neuroblastoma. Cancer Biol Ther. 9:446–452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xin C, Buhe B, Hongting L, Chuanmin Y,
Xiwei H, Hong Z, Lulu H, Qian D and Renjie W: MicroRNA-15a promotes
neuroblastoma migration by targeting reversion-inducing
cysteine-rich protein with Kazal motifs (RECK) and regulating
matrix metal-loproteinase-9 expression. FEBS J. 280:855–866.
2013.
|
|
22
|
Zhao D, Tian Y, Li P, et al: MicroRNA-203
inhibits the malignant progression of neuroblastoma by targeting
Sam68. Mol Med Rep. 12:5554–5560. 2015.PubMed/NCBI
|
|
23
|
Wu K, Yang L, Chen J, et al: miR-362-5p
inhibits proliferation and migration of neuroblastoma cells by
targeting phosphatidylinositol 3-kinase-C2β. FEBS Lett.
589:1911–1919. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su Z, Zhao J, Rong Z, Geng W and Wang Z:
MiR-451, a potential prognostic biomarker and tumor suppressor for
gastric cancer. Int J Clin Exp Pathol. 8:9154–9160. 2015.PubMed/NCBI
|
|
25
|
Guo Y, Hou J, Luo Y and Wang D: Functional
disruption of macrophage migration inhibitory factor (MIF)
suppresses proliferation of human H460 lung cancer cells by
caspase-dependent apoptosis. Cancer Cell Int. 13:282013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Conroy H, Mawhinney L and Donnelly SC:
Inflammation and cancer: Macrophage migration inhibitory factor
(MIF) - the potential missing link. QJM. 103:831–836. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cooke G, Armstrong ME and Donnelly SC:
Macrophage migration inhibitory factor (MIF), enzymatic activity
and the inflammatory response. Biofactors. 35:165–168. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bucala R and Donnelly SC: Macrophage
migration inhibitory factor: A probable link between inflammation
and cancer. Immunity. 26:281–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Oliveira CS, de Bock CE, Molloy TJ,
Sadeqzadeh E, Geng XY, Hersey P, Zhang XD and Thorne RF: Macrophage
migration inhibitory factor engages PI3K/Akt signalling and is a
prognostic factor in metastatic melanoma. BMC Cancer. 14:6302014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Richard V, Kindt N, Decaestecker C, Gabius
HJ, Laurent G, Noël JC and Saussez S: Involvement of macrophage
migration inhibitory factor and its receptor (CD74) in human breast
cancer. Oncol Rep. 32:523–529. 2014.PubMed/NCBI
|
|
31
|
Tan L, Ye X, Zhou Y, Yu M, Fu Z, Chen R,
Zhuang B, Zeng B, Ye H, Gao W, et al: Macrophage migration
inhibitory factor is overexpressed in pancreatic cancer tissues and
impairs insulin secretion function of β-cell. J Transl Med.
12:922014. View Article : Google Scholar
|
|
32
|
Wang D, Luo L, Chen W, Chen LZ, Zeng WT,
Li W and Huang XH: Significance of the vascular endothelial growth
factor and the macrophage migration inhibitory factor in the
progression of hepatocellular carcinoma. Oncol Rep. 31:1199–1204.
2014.
|
|
33
|
Tas F, Karabulut S, Serilmez M, Ciftci R
and Duranyildiz D: Serum levels of macrophage migration-inhibitory
factor (MIF) have diagnostic, predictive and prognostic roles in
epithelial ovarian cancer patients. Tumour Biol. 35:3327–3331.
2014. View Article : Google Scholar
|
|
34
|
Pei XJ, Wu TT, Li B, Tian XY, Li Z and
Yang QX: Increased expression of macrophage migration inhibitory
factor and DJ-1 contribute to cell invasion and metastasis of
nasopharyngeal carcinoma. Int J Med Sci. 11:106–115. 2013.
View Article : Google Scholar
|
|
35
|
Morris KT, Nofchissey RA, Pinchuk IV and
Beswick EJ: Chronic macrophage migration inhibitory factor exposure
induces mesenchymal epithelial transition and promotes gastric and
colon cancers. PLoS One. 9:e986562014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ren Y, Chan HM, Fan J, Xie Y, Chen YX, Li
W, Jiang GP, Liu Q, Meinhardt A and Tam PK: Inhibition of tumor
growth and metastasis in vitro and in vivo by targeting macrophage
migration inhibitory factor in human neuroblastoma. Oncogene.
25:3501–3508. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ren Y, Chan HM, Li Z, Lin C, Nicholls J,
Chen CF, Lee PY, Lui V, Bacher M and Tam PK: Upregulation of
macrophage migration inhibitory factor contributes to induced N-Myc
expression by the activation of ERK signaling pathway and increased
expression of interleukin-8 and VEGF in neuroblastoma. Oncogene.
23:4146–4154. 2004. View Article : Google Scholar : PubMed/NCBI
|
